IQInvest research note
24 SEP 2026 · 23:32 ET
CVS
CVS Health Corporation
$85.05
-$0.81 (-0.94%)down -0.94%
24 September 2026 · delayed 15+ min
F
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
CVS Health Corporation earns a F on strong earnings growth (>20%) and positive free cash flow but current ratio below 1.0 (liquidity concerns) and high debt-to-equity ratio (>2.0). Consider alternatives with better risk/reward profiles.
Adjusted for Moderate investors, Medium-term investors 3.4% suggested allocation Change these
IQ-CVS-20260924engine v1 · 7-category weighted scorecard